Search by Drug Name or NDC

    NDC 00169-2001-90 Insulin Diluting Medium for NovoLog 1 mL/mL Details

    Insulin Diluting Medium for NovoLog 1 mL/mL

    Insulin Diluting Medium for NovoLog is a INTRAVENOUS; SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novo Nordisk. The primary component is WATER.

    Product Information

    NDC 00169-2001
    Product ID 0169-2001_99351c0b-1c32-4eaf-8bc0-68079866d80c
    Associated GPIs
    GCN Sequence Number 074380
    GCN Sequence Number Description diluent, insulin aspart no.1 VIAL INJECTION
    HIC3 C5O
    HIC3 Description DILUENT SOLUTIONS
    GCN 39013
    HICL Sequence Number 042240
    HICL Sequence Number Description DILUENT,INSULIN ASPART COMBINATION NO.1
    Brand/Generic Brand
    Proprietary Name Insulin Diluting Medium for NovoLog
    Proprietary Name Suffix n/a
    Non-Proprietary Name water injection
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS; SUBCUTANEOUS
    Active Ingredient Strength 1
    Active Ingredient Units mL/mL
    Substance Name WATER
    Labeler Name Novo Nordisk
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA020986
    Listing Certified Through 2024-12-31

    Package

    NDC 00169-2001-90 (00169200190)

    NDC Package Code 0169-2001-90
    Billing NDC 00169200190
    Package 1 VIAL, GLASS in 1 CARTON (0169-2001-90) / 10 mL in 1 VIAL, GLASS
    Marketing Start Date 2018-08-01
    NDC Exclude Flag N
    Pricing Information N/A